Skip to content
Saturday, 31 October 2026
Markets

Big Caring’s RM8 Billion IPO: What Should Investors Examine Beyond the Headline?

Big Caring’s proposed RM8 billion valuation puts its IPO in focus. We examine where the proceeds go, how debt repayment could support earnings and what investors should consider about valuation and dividends.

By Edwin Wong4 min read

The pharmacy group’s listing offers exposure to a familiar healthcare business. Its shareholder sell-down, debt repayment plans and earnings valuation deserve equal attention.

KUALA LUMPUR: Big Caring Group Bhd’s proposed listing brings a familiar pharmacy business to the public market. For prospective shareholders, however, the investment decision extends beyond the strength of its retail brands: where will the offering proceeds go, what will the balance sheet look like afterwards, and how much future growth does the price already assume?

The group launched its IPO at a maximum retail price of RM1.08 per share, implying a market capitalisation of approximately RM8 billion, ahead of its scheduled Main Market debut on November 19, 2026.

Its scale provides an established starting point. But familiarity with a pharmacy chain’s stores is different from understanding the financial commitments attached to owning its shares.

Who receives the IPO proceeds?

The offering comprises approximately 590.5 million new shares and up to 1.292 billion existing shares offered by selling shareholders. At the maximum price, these translate into approximately RM637.8 million for the company and RM1.395 billion for the sellers, before any over-allotment.

Based on those figures, roughly 69% of the total offering proceeds would accrue to existing shareholders.

Selling shares through an IPO is an established route for investors to realise part of their investment. The distinction nevertheless matters: proceeds received by selling shareholders do not become funds available for the company’s expansion.

For incoming investors, the question is whether the combination of fresh capital and shareholder sales provides an attractive entry point at the proposed valuation.

How much financial flexibility will debt repayment create?

Big Caring’s announced allocation directs 89.5% of its fresh proceeds towards bank borrowings, with 4.7% earmarked for a new distribution centre and 5.8% for listing expenses.

The immediate financial benefit is therefore principally a reduction in debt and financing costs.

That can be valuable. Lower interest expenses can improve earnings and leave more cash available for operations. It also means investors should distinguish between growth supported directly by new IPO capital and growth expected from the business after its borrowings are reduced.

How much room will remain for new stores, working capital and acquisitions? Will future expansion be financed predominantly through internally generated cash, or will additional borrowing be required?

The Business Times reported planned debt repayments of RM570.7 million and expected annual interest savings of RM26.3 million. Those savings would support profitability, although their timing and eventual amount will depend on the repayment and financing arrangements.

Which profit figure should underpin the valuation?

Investors should also pay attention to the earnings denominator used when discussing the IPO price.

Public reporting puts FY2026 group net profit at approximately RM231.8 million, while profit attributable to the group’s shareholders was approximately RM191.6 million. The latter excludes earnings belonging to minority shareholders in subsidiaries.

Using the approximately RM7.97 billion implied equity valuation, the larger profit figure produces a price-to-earnings ratio of about 34.4 times. Using attributable profit produces approximately 41.6 times.

These are calculations based on the reported figures. For holders of BCG ordinary shares, attributable earnings provide the relevant basis for assessing the historical earnings multiple.

The question is whether future attributable earnings can grow sufficiently to support the price investors are being asked to pay. Any comparison with other listed companies should use consistent earnings definitions and distinguish historical results from forecasts.

Can stronger margins be sustained?

The Business Times reported that gross margin increased from 24.8% to 30.1% in FY2026.

An improvement of that size makes the composition of earnings particularly relevant. Analysis of the business has pointed to purchasing rebates and contributions from higher-margin acquired operations as supporting factors.

Investors would benefit from understanding how much of the improvement reflects recurring purchasing advantages, changes in product mix and the contribution of acquisitions. Comparisons should also establish that costs are classified consistently across periods.

The durability of those gains matters because the valuation rests on earnings that must continue after listing.

What does “up to 50%” mean for dividends?

Big Caring targets a dividend payout of up to 50% of attributable profit, subject to cash availability, gearing, capital expenditure, financing restrictions and working capital requirements.

Management has also indicated that acquisition opportunities could lead to a lower payout, depending on cash flow. The stated policy therefore leaves room for the company to balance distributions against investment needs.

Prospective shareholders should assess that flexibility alongside their own expectations for income and growth. A payout ceiling should not be treated as a promised distribution.

Big Caring’s IPO gives investors an opportunity to own part of an established pharmacy group. Assessing that opportunity requires a clear view of the cash entering the business, the obligations remaining after listing and the earnings available to its shareholders.

The figures discussed here do not establish wrongdoing or a disclosure failure. They identify the financial assumptions on which the investment case depends, and which investors should examine before deciding whether RM1.08 represents an attractive price.

Author

  • Edwin Wong

    Edwin Wong, CEO & Founder of The Ledger Asia